Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation
September 18, 2024 11:15 ET
|
Global Virus Network
DURBAN, South Africa, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Global Virus Network concluded its annual meeting of closed scientific sessions held 16-18 September 2024 with a press conference....
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brain Aging
September 18, 2024 11:07 ET
|
Io Therapeutics, Inc.
Io Therapeutics, Inc., presented on IRX4204 for treatment of brain aging, at the FASEB Conference on Cellular and Molecular Mechanisms of Brain Aging
Starton Therapeutics Announces Successful Feasibility Demonstration of STAR-LLD Using BD Evolve™ On-Body Injector
September 18, 2024 10:46 ET
|
Starton Therapeutics Inc.
Successful feasibility study underscores compatibility of STAR-LLD using On-body Injector (OBI) technology and Starton’s proprietary low-dose formulation of lenalidomide (LLD)Based on the positive...
Historic First Win: House Passes DeOndra Dixon INCLUDE Project Act
September 18, 2024 10:00 ET
|
Global Down Syndrome Foundation
Denver, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Global Down Syndrome Foundation (GLOBAL) is proud to announce that the game-changing DeOndra Dixon INCLUDE Project Act (H.R. 7406) passed the U.S....
SimiTree Unveils Comprehensive Guide to Navigating Home Health and Hospice Billing Challenges in 2024
September 18, 2024 10:00 ET
|
SimiTree
Hamden, CT, Sept. 18, 2024 (GLOBE NEWSWIRE) -- SimiTree, a leading provider of solutions for post-acute care organizations, is pleased to announce the release of its latest whitepaper, "The 2024...
American Kidney Fund’s Rare Kidney Disease Advocacy Day on Capitol Hill Seeks to Gather Support for Legislation that will Increase Awareness and Treatment of Rare Kidney Diseases
September 18, 2024 09:59 ET
|
American Kidney Fund
ROCKVILLE, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Members of AKF’s Rare Kidney Disease Action Network (RKDAN) and health care professionals will visit Capitol Hill in Washington, D.C. today to meet...
Dallas Neurosurgical & Spine Doctors Provide Tips to Take the “Pain” out of National Pain Awareness Month
September 18, 2024 09:46 ET
|
Dallas Neurosurgical & Spine
September is National Pain Awareness Month – an ideal time to explore back pain causes/treatments. Back pain is one of the most common medical conditions.
Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan
September 18, 2024 09:00 ET
|
Scilex Holding Company
PALO ALTO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and...
Marius Pharmaceuticals Partners with UK-Based Numan to Combat Testosterone Deficiency with KYZATREX® (Testosterone Undecanoate) CIII Capsules
September 18, 2024 09:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce a new partnership with Numan, a leading UK-based, VC-backed digital health platform, to introduce...
Revolo Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104
September 18, 2024 08:45 ET
|
Revolo Biotherapeutics
Data continues to differentiate ‘1104 as a potential allergic disease treatment that acts upstream in the immune cascade‘1104 reduces key indices of skin inflammation and inflammatory mediators in a...